Patents Assigned to Pierce Biotechnology, Inc.
  • Patent number: 8889884
    Abstract: A phosphine derivative of DyLight dyes modified with ethylene glycol or (poly)ethylene glycol groups. In one embodiment, the compounds are useful in chemoselective ligation reactions.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: November 18, 2014
    Assignees: Pierce Biotechnology, Inc., Dyomics GmbH
    Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Suk J. Hong, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
  • Publication number: 20140076811
    Abstract: A dialysis device, and a method of dialyzing a sample, are provided. The dialysis device includes a body having a first and a second major side, a first and a second retaining ring disposed on the first and second major sides, and a first and second dialysis membrane disposed, and held between the first and second major sides and the first and second retaining rings. The dialysis device is configured to receive a sample to enable dialysis of the sample across the membranes.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 20, 2014
    Applicant: Pierce Biotechnology, Inc.
    Inventors: Paul Jeffrey Haney, Jeffery James Frank Gordon, Brendan George Metz, Navid R. Haghdoost
  • Publication number: 20130316330
    Abstract: The present invention relates to a non-toxic dipolar solvent for chromogenic substrate for detecting presence of lacZ gene and/or gene activity, which comprises a stabilizing amount of a solubilizing agent. The present invention also relates to a method for inducing lac operon in screening assay, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce the lac operon. The present invention further relates to a method for detecting the presence of bacteria, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce detection of the bacteria.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Applicant: Pierce Biotechnology, Inc.
    Inventors: Pierre Sévigny, Martina Bielefeld-Sévigny
  • Publication number: 20130309689
    Abstract: Methods and sets of non-biological reagents (elution reagents, tag isomers, tag reactive groups, crosslinkers) for single or multiplexed capture and gentle elution of biomolecules. Examples are provided using amine- and cysteine-reactive reagents for enrichment of proteins, peptides, and rare peptide modifications.
    Type: Application
    Filed: March 11, 2013
    Publication date: November 21, 2013
    Applicant: Pierce Biotechnology, Inc.
    Inventors: John Charles Rogers, Ryan Daniel Bomgarden, Christopher Laurence Etienne, Eric Leigh Hommema
  • Patent number: 8572507
    Abstract: Systems and methods to provide users with a user interface at the point of use that provides customizable, interactive protocols, where a protocol is typically an instruction set, procedure, or methodology.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: October 29, 2013
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Kevin Abrams, Douglas Hayworth
  • Publication number: 20130251637
    Abstract: Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.
    Type: Application
    Filed: December 20, 2011
    Publication date: September 26, 2013
    Applicants: DYOMICS GMBH, PIERCE BIOTECHNOLOGY, INC.
    Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
  • Patent number: 8536323
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: September 17, 2013
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Kay Opperman, Barbara J. Kaboord, Jean-Samuel Schultz, Christopher L. Etienne, Greg Hermanson
  • Patent number: 8507291
    Abstract: A method to remove detergents from a biological protein sample that is to be analyzed by mass spectroscopy (MS). The method uses a high performance cyclodextrin polymer resin to remove detergents, which interfere with MS analysis, from a sample containing proteins, peptides, amino acids, etc.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: August 13, 2013
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Babu S. Antharavally, A. Krishna Mallia, Ashok Salunkhe
  • Patent number: 8501433
    Abstract: The present invention relates to a non-toxic dipolar solvent for chromogenic substrate for detecting presence of lacZ gene and/or gene activity, which comprises a stabilizing amount of a solubilizing agent. The present invention also relates to a method for inducing lac operon in screening assay, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce the lac operon. The present invention further relates to a method for detecting the presence of bacteria, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce detection of the bacteria.
    Type: Grant
    Filed: October 31, 2003
    Date of Patent: August 6, 2013
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Pierre Sévigny, Martina Bielefeld-Sévigny
  • Publication number: 20130045488
    Abstract: Compounds useful as labels with properties comparable to known fluorescent compounds. The compounds are conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 21, 2013
    Applicants: Dyomics GmbH, Pierce Biotechnology, Inc.
    Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann, Marie Christine Nlend
  • Publication number: 20130034867
    Abstract: Methods for producing an isotope-labeled mammalian, including a human, biomolecule, such as polypeptides and proteins, in a cell-free protein synthesis system. A biomolecule standard is produced having at least one isotope different in abundance than that of the naturally occurring isotopes in the biomolecule. Methods for quantifying biomolecules standards expressed using mammalian cell-free extracts are disclosed. Methods for producing such standards, kits, systems and reagents, relating to the use of isotope-labeled biomolecule as quantification standards in mass spectrometric and nuclear magnetic resonance analysis.
    Type: Application
    Filed: August 2, 2012
    Publication date: February 7, 2013
    Applicant: Pierce Biotechnology, Inc.
    Inventors: Ryan D. Bomgarden, Eric Leigh Hommema, John Charles Rogers, Penny JoAnn Jensen, Derek Karl Baerenwald
  • Publication number: 20120294807
    Abstract: Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.
    Type: Application
    Filed: December 20, 2011
    Publication date: November 22, 2012
    Applicants: DYOMICS GMBH, PIERCE BIOTECHNOLOGY, INC.
    Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
  • Publication number: 20120252691
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Application
    Filed: May 29, 2012
    Publication date: October 4, 2012
    Applicant: Pierce Biotechnology, Inc.
    Inventors: Christopher L. Etienne, Kay K. Opperman, Barbara J. Kaboord, Scott Meier, Jean-Samuel Schultz
  • Publication number: 20120217203
    Abstract: A dialysis system including a generally sealed vessel configured to receive a buffer, and a dialysis device positioned in the generally sealed vessel. The dialysis device includes an inner member and an outer member trapping a dialysis membrane between the members. The dialysis device is configured to receive a sample to enable dialysis of the sample with respect to the buffer across the membrane.
    Type: Application
    Filed: January 6, 2012
    Publication date: August 30, 2012
    Applicant: Pierce Biotechnology, Inc.
    Inventors: Paul Jeffrey Haney, Brian L. Webb, Navid Reza Haghdoost, Rizwan Farooqui, Atul Madhukar Deshpande
  • Publication number: 20120156140
    Abstract: Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.
    Type: Application
    Filed: December 20, 2011
    Publication date: June 21, 2012
    Applicants: DYOMICS GMBH, PIERCE BIOTECHNOLOGY, INC.
    Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
  • Patent number: 8192948
    Abstract: A kit for enhanced detection of analytes that produce peroxide or peroxidase activity.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: June 5, 2012
    Assignee: Pierce Biotechnology, Inc.
    Inventor: Kelli D. Feather-Henigan
  • Publication number: 20110289442
    Abstract: Systems and methods to provide users with a user interface at the point of use that provides customizable, interactive protocols, where a protocol is typically an instruction set, procedure, or methodology.
    Type: Application
    Filed: March 17, 2011
    Publication date: November 24, 2011
    Applicant: Pierce Biotechnology, Inc.
    Inventors: Kevin Abrams, Douglas Hayworth
  • Publication number: 20110262917
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Application
    Filed: April 20, 2011
    Publication date: October 27, 2011
    Applicant: PIERCE BIOTECHNOLOGY, INC.
    Inventors: Kay Opperman, Barbara J. Kaboord, Jean-Samuel Schultz, Christopher L. Etienne, Greg Hermanson
  • Patent number: 8039648
    Abstract: Compounds used as dyes comparable to Alexa Fluor 350 dyes. The inventive compounds have high fluorescence quantum yield and high photostability. The dyes facilitate analysis of biological structures with enhanced sensitivity and selectivity.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: October 18, 2011
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann, Bernd G. Schweder, Wilhelm G. Frank
  • Patent number: 8007668
    Abstract: A device for dialysis of a sample includes a sample chamber formed by a gasket and dialysis membranes affixed to each side of the gasket in facing relationship. A housing supports the dialysis membranes and gasket. An air chamber causes the device to float in a generally upright position when the device is immersed in a dialysate. An access port is provided through the gasket and between the dialysis membranes. The access port is accessible from outside the housing and in communication with the sample chamber such that a dispensing end of a dispensing device can be inserted through the access port to dispense sample into the sample chamber. In one embodiment, the gasket is impermeable or essentially impermeable to the sample being dialyzed.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: August 30, 2011
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Paul J. Haney, Michael Robert Johnston